PSI CRO will demonstrate how its AI-enabled semantic knowledge platform applies natural language processing, knowledge graphs, and predictive analytics to identify enrollment risks and rank sites by enrollment potential before activation at SCOPEEurope2026 in Barcelona on 13 October 2026.
Published
Signal category
Presence & Recognition
Quote
“At #SCOPEEurope2026, Emily McInturf and Andrei Seryi will demonstrate how PSI CRO’s AI-enabled semantic knowledge platform applies natural language processing, knowledge graphs, and predictive analytics to identify enrollment risks earlier and rank sites by enrollment potential before activation.”
— PSI CRO team
Company
- Industry
- Pharmaceutical Manufacturing
- Location
- Zug, CH
- Company size
- 2,969 employees
PSI is a leading full-service global Contract Research Organization whose key strength is predictable patient enrollment across multiple therapeutic areas. PSI is known in the industry as a CRO focused on ‘on-time project delivery’. This is achieved through investing substantial effort and MD resources into performing quality feasibility assessments that provide an accurate predictor of study timelines. PSI’s global reach allows us to run clinical trials across multiple continents, in 50+ countries around the world. PSI’s reputation is that of a 'no-nonsense' CRO focused on timely patient enrollment and project delivery. An exceptionally high repeat and referral business rates alongside low staff turnover are indicative of our commitment to be the best CRO in the world as measured by our clients and our employees. http://www.psi-cro.com